Table of Contents

You may also like:

Vaccine hope, EU fund fuel rally, down the dollar amid US-Sino tensions ahead of Powell

The market mood remains upbeat after a risk rally on Monday, driven by hopes of a vaccine, a Franco-German fund plan, a bounce in Chinese oil usage, and the Fed’s commitment to supporting the economy. Gold fell after shooting to the highest since 2012. Rising US-Sino tensions and testimony from Jerome Powell, Chairman of the Federal Reserve are eyed.

Vaccine? Moderna, a Massachusets-based pharmaceutical firm said its immunization candidate to COVID-19 showed promising results, as the eight people participating in the experiment produced antibodies. While this was only the first stage, hopes for a vaccine sent stocks rallying. A broad test begins in July.

German ZEW Economic Sentiment for May is set to show a marginal increase from April’s 25.2 points. Business confidence is critical to a comeback.

Central bank commitment: The Federal Reserve released Chair Powell’s remarks in testimony later today. He vowed to add stimulus as much as needed and pledged to leave interest rates low until America returns to full employment. His more positive take has also contributed to the upbeat market mood.

UK: GBP/USD has also recovered, with the pound shrugging off fraught Brexit talks and also the growing chances of negative interest rates. Silvana Tenreyro, an external member of the Bank of England’s Monetary Policy Committee, said that the policy has been successful in the eurozone.

The Australian dollar has been holding up, consolidating its gains from the risk-on move despite rising tensions with China. Beijing slapped an 80% tariff on Australian barley. NZD/USD is in a similar position after officials at the Reserve Bank of New Zealand said the kiwi’s exchange rate is supporting exports.

https://www.fxstreet.com/news/forex-today-vaccine-hope-eu-fund-fuel-rally-down-the-dollar-amid-us-sino-tensions-ahead-of-powell-202005190537

According to Trading Central (3rd party RIA) the EURAUD is long positions above 1.6650 with targets at 1.6855&1.6913 in extension.

* Past performance is not a guarantee of future performance

https://europefx.tradingcentral.com/Product?PK_ANALYSE=10745644

Number of Lots:Required Margin:Risk Management (50%):Potential Profit/Loss 1.6855
1€ 5,000.00€ 2,500.00€ 897.75
5€ 25,000.00€ 50,000.00€ 4,488.75
10€ 50,000.00€ 100,000.00€ 8,977.50
25€ 125,000.00€ 250,000.00€ 22,443.75
50€ 250,000.00€ 500,000.00€ 44,887.50

According to Trading Central (3rd party RIA) the EURNZD is long positions above 1.7976 with targets at 1.8166&1.8221 in extension.

* Past performance is not a guarantee of future performance

https://europefx.tradingcentral.com/Product?PK_ANALYSE=10745836

Number of Lots:Required Margin:Risk Management (50%):Potential Profit/Loss 1.8166
1€ 5,000.00€ 2,500.00€ 1,090.74
5€ 25,000.00€ 50,000.00€ 5,453.70
10€ 50,000.00€ 100,000.00€ 10,907.40
25€ 125,000.00€ 250,000.00€ 27,268.50
50€ 250,000.00€ 500,000.00€ 54,537.00

According to Trading Central (3rd party RIA) the NASDAQ is long positions above 9250.00 with targets at 9446.00 & 9555.00 in extension.

* Past performance is not a guarantee of future performance

https://europefx.tradingcentral.com/Product?PK_ANALYSE=10745671

Number of Lots:Required Margin:Risk Management (50%):Potential Profit/Loss 9446
0.5€ 21,490.83€ 10,745.41€ 3,486.24
1€ 42,981.65€ 21,490.83€ 6,972.48
5€ 214,908.26€ 107,454.13€ 34,862.39
10€ 429,816.51€ 214,908.26€ 69,724.77
20€ 859,633.03€ 429,816.51€ 139,449.54

 

Risk Disclaimer: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.61% of retail investor accounts lose money when trading CFDs with this provider. The above charts and any information provided therein are indicative and subjective to the technical analysis method or trading patterns used and the timing of their release. Those are provided as general market information and/or market commentary and/or the publication of market/factual data and should not be construed as containing personal and/or other investment recommendation, and/or to be Investment Advice or independent Investment Research. As such, the legal and regulatory requirements in relation to independent investment research do not apply to this material and it is not subject to any prohibition on dealing ahead of its dissemination. For the full Risk Disclaimer click here. The information contained in this market review should not be construed in any way, as containing investment advice and/or a suggestion and/or solicitation for any trading activity and financial transaction. The material is for general information purposes only (whether or not it states any opinions). Nothing in this material is (or should be considered to be) legal, financial, investment or other advice on which reliance should be placed. The data contained in this market review is not necessarily real-time nor accurate. The data and prices on the material are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. There is no guarantee and/or prediction of future performance. EuropeFX, its affiliates, agents, directors or employees do not guarantee the accuracy and validity of any information or data made available and assume no liability as to any loss arising from any investment based on the same. Trading Forex/CFD’s carries a high level of risk and can result in the loss of your whole investment. Forex/CFD’s are leveraged products and therefore Forex/CFD’s trading may not be appropriate for all investors. It is recommended that you do not invest more money than you can afford to lose to avoid significant financial problems in the case of losses. Please make sure you define the maximum risk acceptable for yourself. No opinion given in the material constitutes a recommendation by EuropeFX or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. Although the information set out in this marketing communication is obtained from sources believed to be reliable, EuropeFX makes no guarantee as to its accuracy or completeness. All information is indicative and subject to change without notice and may be out of date at any given time. Neither EuropeFX nor the author of this material shall be responsible for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein. Seek independent advice if required.